Call Today216.600.0114
Spangenberg Shibley & Liber, LLP | Mar 1, 2012

Spangenberg Shibley & Liber Investigating Crestor Type 2 Diabetes Claims

Categories: News
Studies have shown that people taking cholesterol-lowering statins such as Crestor have a higher risk of developing type 2 diabetes. Doctors believe the drugs raise blood sugar levels. This prompted the FDA to approve warning label changes for statin drugs in February 2012.